Source record
Why custom does not mean approved
A compounded medicine is prepared to order.
Before a compounded medicine is sold, the FDA does not review its quality, safety or how well it works, as of September 26, 2026.
Read the sourceBegin
What is a peptide treatment?
Begin with a name and a purpose. What is the proposed medicine? Which health problem would it treat?
“Peptide” names the material.
Peptides are short strings made from the same small parts as proteins.
Insulin is one example of a peptide.
As of September 26, 2026, “peptide therapy” is not a separate category in U.S. drug law.
That leaves a more useful question: what product is being offered? Write its full name, including any extra ingredient, rather than just the word peptide.
“Treatment” needs a purpose.
Put the goal into ordinary words. Is the concern weight, blood sugar, or something else? Ask the clinician to explain what result they are trying to achieve and how they would judge it.
A useful answer names the medicine, the health problem and the reason for choosing it. Ask what other approaches were considered.
“Approved” applies to a product.
U.S. approvals cover products with semaglutide (Ozempic, Wegovy) as well as tirzepatide (Mounjaro, Zepbound), as of September 26, 2026.
Those approvals do not extend to a pharmacy’s custom version of either drug.
Ask for the exact medicine name. Ask which health problem the medicine would treat. A claim about a clinic does not answer those questions.